Mark Velleca

Former Director at G1 Therapeutics, Inc.

Mark Velleca

Mark Velleca

Former Director at G1 Therapeutics, Inc.

Overview
Career Highlights

G1 Therapeutics, Inc.

RelSci Relationships

1679

Number of Boards

4

Birthday

1964

Age

57

Contact Data
Trying to get in touch with Mark Velleca? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Mark Velleca likely has professional access to. A relationship does not necessarily indicate a personal connection.

Advisor to Chief Executive Officer at Abyrx, Inc.

Relationship likelihood: Strong

Former President at G1 Therapeutics, Inc.

Relationship likelihood: Strong

Chief Financial & Business Officer at Entasis Therapeutics, Inc.

Relationship likelihood: Strong

President at UnitedHealth Group, Inc.

Relationship likelihood: Strong

Former Executive Vice President, Finance & Administration, Assistant Treasurer & Assistant Secretary at Hologic, Inc.

Relationship likelihood: Strong

General Partner at Hatteras Venture Partners

Relationship likelihood: Strong

Chief Executive Officer at Innocrin Pharmaceuticals, Inc.

Relationship likelihood: Strong

Executive Director-Corporate Development at AstraZeneca Plc

Relationship likelihood: Strong

President & Chief Executive Officer at G1 Therapeutics, Inc.

Relationship likelihood: Strong

Chief Financial Officer at G1 Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Mark Velleca
Potential Connections via
Relationship Science
You
Mark Velleca
Former Director at G1 Therapeutics, Inc.
Education
BS, cum laude

Yale University is an American private Ivy League research university located in New Haven, Connecticut. Founded in 1701 in the Colony of Connecticut, the university is the third-oldest institution of higher education in the United States.

PhD

The mission of Washington University in St. Louis is the promotion of learning — learning by students and by faculty. Teaching, the transmission of knowledge, is central to our mission, as is research, the creation of new knowledge. Faculty — composed of scholars, scientists, artists and members of the learned professions — serve society by teaching; by adding to the store of human art, creativity, understanding, and wisdom; and by providing direct services, such as health care. The university offers more than 90 programs and almost 1,500 courses leading to bachelor's, master's and doctoral degrees in a broad spectrum of traditional and interdisciplinary fields, with additional opportunities for minor concentrations and individualized programs.

MD

A leader in medical research, teaching and patient care, Washington University School of Medicine is currently ranked fourth in the nation by U.S. News & World Report. The School’s 2,100 employed and volunteer faculty physicians and clinicians -- known as Washington University Physicians -- are also medical staff members of Barnes-Jewish and St. Louis Children’s hospitals. The clinical practice group provides care to more than 430,000 children and adults at 49 clinical sites annually. Together, the institutions located on the Washington University Medical Center campus employ more than 21,000 clinicians, scientists, residents, fellows, administrators and support staff.

Career History
Director
2014 - 2021

G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.

Chief Policy
2012 - 2014

The Leukemia & Lymphoma Society's New York City Chapter was founded to serve residents who have been touched by one of the blood cancers: leukemia, lymphoma and myeloma. The chapter serves the five boroughs of New York City.

Senior Vice President
2000 - Prior

Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
N/A
2010

The MBL is an international center for research, education, and training in biology, biomedicine, and environmental science. The oldest private marine laboratory in the country, the MBL has a year-round staff of more than 270 scientists and support personnel working in such fields as cell, developmental, and regenerative biology, ecology, microbiology, genetics and metagenomics, neurobiology, sensory biology, and biodiversity informatics. Each summer, an additional 1,700 scientists and advanced students from around the world come to the MBL to study and conduct research. The MBL’s educational program, which offers seven major summer courses and approximately twenty special topics courses throughout the year, plays a significant role in training the world's biologists and environmental scientists

N/A
2009

The MBL is an international center for research, education, and training in biology, biomedicine, and environmental science. The oldest private marine laboratory in the country, the MBL has a year-round staff of more than 270 scientists and support personnel working in such fields as cell, developmental, and regenerative biology, ecology, microbiology, genetics and metagenomics, neurobiology, sensory biology, and biodiversity informatics. Each summer, an additional 1,700 scientists and advanced students from around the world come to the MBL to study and conduct research. The MBL’s educational program, which offers seven major summer courses and approximately twenty special topics courses throughout the year, plays a significant role in training the world's biologists and environmental scientists

N/A
2008

The MBL is an international center for research, education, and training in biology, biomedicine, and environmental science. The oldest private marine laboratory in the country, the MBL has a year-round staff of more than 270 scientists and support personnel working in such fields as cell, developmental, and regenerative biology, ecology, microbiology, genetics and metagenomics, neurobiology, sensory biology, and biodiversity informatics. Each summer, an additional 1,700 scientists and advanced students from around the world come to the MBL to study and conduct research. The MBL’s educational program, which offers seven major summer courses and approximately twenty special topics courses throughout the year, plays a significant role in training the world's biologists and environmental scientists

Transactions
Details Hidden

G1 Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

G1 Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

G1 Therapeutics, Inc. raised money in a private placement transaction

Investments
Details Hidden

Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Mark Velleca. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Mark Velleca's profile does not indicate a business or promotional relationship of any kind between RelSci and Mark Velleca.